- Home
- BILI vs PEN Comparison
BILI vs PEN Comparison
Compare BILI & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BILI
- PEN
- Stock Information
- Founded
- BILI 2009
- PEN 2004
- Country
- BILI China
- PEN United States
- Employees
- BILI N/A
- PEN N/A
- Industry
- BILI EDP Services
- PEN Medical/Dental Instruments
- Sector
- BILI Technology
- PEN Health Care
- Exchange
- BILI Nasdaq
- PEN Nasdaq
- Market Cap
- BILI 8.8B
- PEN 9.0B
- IPO Year
- BILI 2018
- PEN 2015
- Fundamental
- Price
- BILI $22.60
- PEN $233.24
- Analyst Decision
- BILI Buy
- PEN Strong Buy
- Analyst Count
- BILI 8
- PEN 16
- Target Price
- BILI $23.25
- PEN $302.40
- AVG Volume (30 Days)
- BILI 2.9M
- PEN 439.4K
- Earning Date
- BILI 08-21-2025
- PEN 07-29-2025
- Dividend Yield
- BILI N/A
- PEN N/A
- EPS Growth
- BILI N/A
- PEN N/A
- EPS
- BILI N/A
- PEN 1.08
- Revenue
- BILI $3,882,060,637.00
- PEN $1,240,100,000.00
- Revenue This Year
- BILI $15.65
- PEN $14.60
- Revenue Next Year
- BILI $8.71
- PEN $14.24
- P/E Ratio
- BILI N/A
- PEN $210.71
- Revenue Growth
- BILI 21.83
- PEN 13.17
- 52 Week Low
- BILI $12.72
- PEN $148.00
- 52 Week High
- BILI $31.77
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- BILI 49.05
- PEN 35.01
- Support Level
- BILI $24.01
- PEN $229.13
- Resistance Level
- BILI $25.38
- PEN $235.40
- Average True Range (ATR)
- BILI 0.57
- PEN 4.99
- MACD
- BILI -0.24
- PEN 0.00
- Stochastic Oscillator
- BILI 25.68
- PEN 26.65
About BILI Bilibili Inc.
Bilibili is a Chinese online entertainment platform best known for its YouTube-like video-sharing site. Founded in 2009, it initially focused on long-form content centered around anime, comics, and gaming, catering primarily to Gen Z users. Over time, the platform has broadened its content offerings to include a wider range of interests, successfully attracting a more diverse audience beyond the Gen Z demographic.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.